Spin-out companies
Spin-out Companies
We have created over 100 spinout companies, more than any other Midlands University.
Work with our spin-outs
Could you be a mentor, CEO or board member? Get in touch to connect with our spin-outs.
UK GOVERNMENT SPINOUT REVIEW: STATEMENT OF BEST PRACTICE ADOPTION
29 May 2024
Warwick Innovations welcomed the UK Government Spinout Review and the opportunity to revise the University’s institutional policies and practice around spinout company development. The university is committed to update policy and practice (subject to UEB and FGPC approval) to better align with recommendations from the Spinout Review. Key policy changes under consideration at Warwick are to:
- reduce the university’s equity stake in future spinouts down to around 30%; and
- to recognise academic founders in addition to creators in being able to benefit from shares in spinout equity.
Other key changes in spinout company development and support being implemented at Warwick are to:
- define, communicate and refine steps and timelines for spinout company formation, including clarity on expectations from key stakeholders;
- embed a new process to better manage, support and report on spinout portfolio performance;
- deliver a campus-wide marcomms campaign to raise awareness of changes in our spinout policy and practice; and
- roll-out a series of internal programmes to upskill the research community in commercialisation skills and innovation leadership.
Lightcast Discovery
Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function.
Clinvivo
Clinvivo Ltd. specialise in data capture in clinical trials of complex interventions and health research.
OVO Biomanufacturing
OVO Biomanufacturing are the world leading experts in providing technical solutions to solve the effects of defective interfering particles for viral vaccine manufacturers.
NanoSyrinx Ltd
NanoSyrinx is a discovery stage synthetic biology company creating a next-generation platform technology for the targeted intracellular delivery of biological molecules.
Medherant
Improving patient care through innovation in transdermal drug delivery.
Histofy
Optimising cellular pathology with cutting-edge artificial intelligence
Erebagen
Erebagen is a synthetic biology company that discovers truly novel bioactive products from microbes by activating previously silent gene clusters.
Cytoswim
Developing the next generation of sperm conditioning tools that enable IVF practitioners to more effectively separate out the best sperm cells.
CryoLogyx
CryoLogyx provides ready-to-use cells for drug discovery and toxicology. Our cells are cryopreserved & plated, so they are ready to use 24 hours post-thaw.
Biofidelity
Biomarker testing technology developed to provide comprehensive biomarker results within days of diagnosis, giving physicians the opportunity to offer their patients the best possible treatment options.
4D Biomaterials
Pioneering the commercialisation of a new class of 3D printable resorbable biomaterials for diverse medical applications.
NeuroSolutions
NeuroSolutions is a contract research organisation established in 2001 as a service provider of cutting edge electrophysiological and behavioural research in the field of neuroscience.